Contact Information
Company Information
Company
康希诺生物股份公司 CanSino Biologics Inc.
Annual Revenue
674610000.0
Technologies
Mobile Friendly
Nginx
Basis
AI
Keywords
and
biotechnology research
biopharmaceutical
vaccines
infectious diseases
research & development
vaccine manufacturing
vaccine commercialization
clinical trials
mrna technology
adenovirus-based vaccine
vaccine pipeline
vaccine product portfolio
innovative vaccines
vaccine quality assurance
vaccine distribution
public health
cellular immunity
humoral immunity
pathogen antigen
vaccine formulation
synthetic biotechnology
immunogenicity
conjugate vaccines
virus-like particles
multivalent vaccines
tetanus vaccine
meningococcal vaccine
covid-19 vaccine
ebola vaccine
pneumonia vaccine
pertussis vaccine
tuberculosis vaccine
shingles vaccine
hospital collaboration
global health solutions
clinical trial approvals
gmp compliance
halal certification
direct sales model
international production standards
vaccine safety
pipeline innovation
novel vaccine development
prevention strategies
healthcare partnerships
proprietary technology
vaccine research collaboration
health care
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans